ID

23897

Description

Study part: Medication. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Mots-clés

Versions (1)
  1. 17/07/2017 17/07/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

17 juillet 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Medication Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Anglais

Medication

1 Formulaires  
  1. StudyEvent: ODM
    1. Medication
MEDICATION
Description

MEDICATION

Alias
UMLS CUI-1
C0013227
Subject number
Description

Subject number

Type de données

integer

Alias
UMLS CUI [1]
C2348585
Have any medications/treatments been administered during study period?
Description

medication

Type de données

boolean

Alias
UMLS CUI [1]
C0013227
Trade / Generic Name
Description

Trade / Generic Name

Type de données

text

Alias
UMLS CUI [1]
C0027365
Medical Indication- Prophylactic
Description

Medical Indication- Prophylactic

Type de données

boolean

Alias
UMLS CUI [1,1]
C0199176
UMLS CUI [1,2]
C3146298
UMLS CUI [1,3]
C0013227
Medical Indication
Description

Medical Indication

Type de données

text

Alias
UMLS CUI [1]
C2315323
Total daily dose
Description

Total daily dose

Type de données

text

Alias
UMLS CUI [1]
C2348070
Route
Description

Route

Type de données

text

Alias
UMLS CUI [1]
C0013153
Start date
Description

Start date

Type de données

date

Alias
UMLS CUI [1]
C0808070
End date
Description

End date

Type de données

date

Alias
UMLS CUI [1]
C0806020
Medication continuing at end of study?
Description

medication ongoing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C3174772
Retour au début de la page

Similar models

Medication

1 Formulaires
  1. StudyEvent: ODM
    1. Medication
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
MEDICATION
C0013227 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
medication
Item
Have any medications/treatments been administered during study period?
boolean
C0013227 (UMLS CUI [1])
Trade / Generic Name
Item
Trade / Generic Name
text
C0027365 (UMLS CUI [1])
Medical Indication- Prophylactic
Item
Medical Indication- Prophylactic
boolean
C0199176 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Medical Indication
Item
Medical Indication
text
C2315323 (UMLS CUI [1])
Total daily dose
Item
Total daily dose
text
C2348070 (UMLS CUI [1])
Route
Item
Route
text
C0013153 (UMLS CUI [1])
Start date
Item
Start date
date
C0808070 (UMLS CUI [1])
End date
Item
End date
date
C0806020 (UMLS CUI [1])
medication ongoing
Item
Medication continuing at end of study?
boolean
C0013227 (UMLS CUI [1,1])
C3174772 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial